Annual EBITDA
-$37.98 M
-$9.72 M-34.39%
December 31, 2022
Summary
- As of February 27, 2025, NH annual EBITDA is -$37.98 million, with the most recent change of -$9.72 million (-34.39%) on December 31, 2022.
- During the last 3 years, NH annual EBITDA has fallen by -$11.99 million (-46.14%).
Performance
NH EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly EBITDA
-$18.19 M
-$12.05 M-196.19%
December 31, 2022
Summary
- As of February 27, 2025, NH quarterly EBITDA is -$18.19 million, with the most recent change of -$12.05 million (-196.19%) on December 31, 2022.
- Over the past year, NH quarterly EBITDA has dropped by -$9.22 million (-102.82%).
Performance
NH Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM EBITDA
-$37.98 M
-$9.22 M-32.06%
December 31, 2022
Summary
- As of February 27, 2025, NH TTM EBITDA is -$37.98 million, with the most recent change of -$9.22 million (-32.06%) on December 31, 2022.
- Over the past year, NH TTM EBITDA has dropped by -$9.72 million (-34.39%).
Performance
NH TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
NH EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -34.4% | -102.8% | -34.4% |
| 3 y3 years | -46.1% | -338.8% | -46.1% |
| 5 y5 years | +57.5% | -13.9% | -46.1% |
NH EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | +34.4% | at low | +250.7% | at low | +45.9% | at low |
| 5 y | 5-year | +46.1% | +37.0% | <-9999.0% | +116.9% | +127.0% | +58.6% |
| alltime | all time | +46.1% | +307.1% | -232.0% | +391.0% | +262.3% | +307.1% |
NantHealth EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | -$37.98 M(+34.4%) | -$18.19 M(+196.2%) | -$37.98 M(+32.1%) |
| Sep 2022 | - | -$6.14 M(+18.4%) | -$28.76 M(+10.5%) |
| Jun 2022 | - | -$5.19 M(-38.8%) | -$26.04 M(-8.9%) |
| Mar 2022 | - | -$8.47 M(-5.6%) | -$28.59 M(+1.2%) |
| Dec 2021 | -$28.27 M(-45.7%) | -$8.97 M(+162.5%) | -$28.26 M(-6.3%) |
| Sep 2021 | - | -$3.42 M(-55.8%) | -$30.16 M(+5.7%) |
| Jun 2021 | - | -$7.74 M(-4.9%) | -$28.54 M(-52.6%) |
| Mar 2021 | - | -$8.14 M(-25.1%) | -$60.24 M(+15.8%) |
| Dec 2020 | -$52.02 M(+100.1%) | -$10.87 M(+506.9%) | -$52.02 M(+14.8%) |
| Sep 2020 | - | -$1.79 M(-95.5%) | -$45.30 M(-9.9%) |
| Jun 2020 | - | -$39.44 M(<-9900.0%) | -$50.26 M(+200.3%) |
| Mar 2020 | - | $81.00 K(-102.0%) | -$16.74 M(-35.6%) |
| Dec 2019 | -$25.99 M(-83.2%) | -$4.14 M(-38.6%) | -$25.99 M(-57.5%) |
| Sep 2019 | - | -$6.75 M(+14.1%) | -$61.09 M(-57.5%) |
| Jun 2019 | - | -$5.92 M(-35.5%) | -$143.64 M(-4.4%) |
| Mar 2019 | - | -$9.18 M(-76.6%) | -$150.28 M(-2.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | -$154.63 M(+73.0%) | -$39.24 M(-56.1%) | -$154.63 M(+17.7%) |
| Sep 2018 | - | -$89.30 M(+611.1%) | -$131.35 M(+142.7%) |
| Jun 2018 | - | -$12.56 M(-7.2%) | -$54.12 M(-37.9%) |
| Mar 2018 | - | -$13.53 M(-15.2%) | -$87.12 M(-2.5%) |
| Dec 2017 | -$89.38 M(-29.6%) | -$15.96 M(+32.3%) | -$89.38 M(-23.5%) |
| Sep 2017 | - | -$12.06 M(-73.5%) | -$116.81 M(-4.4%) |
| Jun 2017 | - | -$45.56 M(+188.6%) | -$122.15 M(-9.9%) |
| Mar 2017 | - | -$15.79 M(-63.6%) | -$135.51 M(-8.4%) |
| Dec 2016 | -$126.96 M(+339.5%) | -$43.40 M(+149.3%) | -$147.96 M(+63.0%) |
| Sep 2016 | - | -$17.41 M(-70.5%) | -$90.78 M(-1.0%) |
| Jun 2016 | - | -$58.92 M(+108.7%) | -$91.71 M(+96.7%) |
| Mar 2016 | - | -$28.24 M(-304.9%) | -$46.63 M(+61.5%) |
| Dec 2015 | -$28.88 M(-57.2%) | $13.78 M(-175.2%) | -$28.88 M(-32.3%) |
| Sep 2015 | - | -$18.33 M(+32.4%) | -$42.66 M(+75.4%) |
| Jun 2015 | - | -$13.85 M(+32.1%) | -$24.33 M(+132.1%) |
| Mar 2015 | - | -$10.48 M | -$10.48 M |
| Dec 2014 | -$67.45 M | - | - |
FAQ
- What is NantHealth annual EBITDA?
- What is the all time high annual EBITDA for NantHealth?
- What is NantHealth annual EBITDA year-on-year change?
- What is NantHealth quarterly EBITDA?
- What is the all time high quarterly EBITDA for NantHealth?
- What is NantHealth quarterly EBITDA year-on-year change?
- What is NantHealth TTM EBITDA?
- What is the all time high TTM EBITDA for NantHealth?
- What is NantHealth TTM EBITDA year-on-year change?
What is NantHealth annual EBITDA?
The current annual EBITDA of NH is -$37.98 M
What is the all time high annual EBITDA for NantHealth?
NantHealth all-time high annual EBITDA is -$25.99 M
What is NantHealth annual EBITDA year-on-year change?
Over the past year, NH annual EBITDA has changed by -$9.72 M (-34.39%)
What is NantHealth quarterly EBITDA?
The current quarterly EBITDA of NH is -$18.19 M
What is the all time high quarterly EBITDA for NantHealth?
NantHealth all-time high quarterly EBITDA is $13.78 M
What is NantHealth quarterly EBITDA year-on-year change?
Over the past year, NH quarterly EBITDA has changed by -$9.22 M (-102.82%)
What is NantHealth TTM EBITDA?
The current TTM EBITDA of NH is -$37.98 M
What is the all time high TTM EBITDA for NantHealth?
NantHealth all-time high TTM EBITDA is -$10.48 M
What is NantHealth TTM EBITDA year-on-year change?
Over the past year, NH TTM EBITDA has changed by -$9.72 M (-34.39%)